Single Molecule Analysis of Replicated DNA Reveals the Usage of Multiple KSHV Genome Regions for Latent Replication
Kaposi's sarcoma associated herpesvirus (KSHV), an etiologic agent of Kaposi's sarcoma, Body Cavity Based Lymphoma and Multicentric Castleman's Disease, establishes lifelong latency in infected cells. The KSHV genome tethers to the host chromosome with the help of a latency associated nuclear antigen (LANA). Additionally, LANA supports replication of the latent origins within the terminal repeats by recruiting cellular factors. Our previous studies identified and characterized another latent origin, which supported the replication of plasmids ex-vivo without LANA expression in trans. Therefore identification of an additional origin site prompted us to analyze the entire KSHV genome for replication initiation sites using single molecule analysis of replicated DNA (SMARD). Our results showed that replication of DNA can initiate throughout the KSHV genome and the usage of these regions is not conserved in two different KSHV strains investigated. SMARD also showed that the utilization of multiple replication initiation sites occurs across large regions of the genome rather than a specified sequence. The replication origin of the terminal repeats showed only a slight preference for their usage indicating that LANA dependent origin at the terminal repeats (TR) plays only a limited role in genome duplication. Furthermore, we performed chromatin immunoprecipitation for ORC2 and MCM3, which are part of the pre-replication initiation complex to determine the genomic sites where these proteins accumulate, to provide further characterization of potential replication initiation sites on the KSHV genome. The ChIP data confirmed accumulation of these pre-RC proteins at multiple genomic sites in a cell cycle dependent manner. Our data also show that both the frequency and the sites of replication initiation vary within the two KSHV genomes studied here, suggesting that initiation of replication is likely to be affected by the genomic context rather than the DNA sequences.
Vyšlo v časopise:
Single Molecule Analysis of Replicated DNA Reveals the Usage of Multiple KSHV Genome Regions for Latent Replication. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002365
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002365
Souhrn
Kaposi's sarcoma associated herpesvirus (KSHV), an etiologic agent of Kaposi's sarcoma, Body Cavity Based Lymphoma and Multicentric Castleman's Disease, establishes lifelong latency in infected cells. The KSHV genome tethers to the host chromosome with the help of a latency associated nuclear antigen (LANA). Additionally, LANA supports replication of the latent origins within the terminal repeats by recruiting cellular factors. Our previous studies identified and characterized another latent origin, which supported the replication of plasmids ex-vivo without LANA expression in trans. Therefore identification of an additional origin site prompted us to analyze the entire KSHV genome for replication initiation sites using single molecule analysis of replicated DNA (SMARD). Our results showed that replication of DNA can initiate throughout the KSHV genome and the usage of these regions is not conserved in two different KSHV strains investigated. SMARD also showed that the utilization of multiple replication initiation sites occurs across large regions of the genome rather than a specified sequence. The replication origin of the terminal repeats showed only a slight preference for their usage indicating that LANA dependent origin at the terminal repeats (TR) plays only a limited role in genome duplication. Furthermore, we performed chromatin immunoprecipitation for ORC2 and MCM3, which are part of the pre-replication initiation complex to determine the genomic sites where these proteins accumulate, to provide further characterization of potential replication initiation sites on the KSHV genome. The ChIP data confirmed accumulation of these pre-RC proteins at multiple genomic sites in a cell cycle dependent manner. Our data also show that both the frequency and the sites of replication initiation vary within the two KSHV genomes studied here, suggesting that initiation of replication is likely to be affected by the genomic context rather than the DNA sequences.
Zdroje
1. VermaSCRobertsonES 2003 Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222 155 163
2. MoorePSChangY 2003 Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 57 609 639
3. ChangYCesarmanEPessinMSLeeFCulpepperJ 1994 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 1865 1869
4. RenneRLagunoffMZhongWGanemD 1996 The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70 8151 8154
5. CotterMA2ndRobertsonES 1999 The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 254 264
6. BallestasMEChatisPAKayeKM 1999 Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 641 644
7. ZhongWWangHHerndierBGanemD 1996 Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 93 6641 6646
8. MeansREChoiJKNakamuraHChungYHIshidoS 2002 Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. Curr Top Microbiol Immunol 269 187 201
9. LiangCLeeJSJungJU 2008 Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin Cancer Biol 18 423 436
10. RainbowLPlattGMSimpsonGRSaridRGaoSJ 1997 The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71 5915 5921
11. RenneRBlackbournDWhitbyDLevyJGanemD 1998 Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72 5182 5188
12. FloreORafiiSElySO'LearyJJHyjekEM 1998 Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394 588 592
13. FriborgJJrKongWHottigerMONabelGJ 1999 p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402 889 894
14. MoorePSChangY 1998 Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr 65 71
15. FujimuroMWuFYApRhysCKajumbulaHYoungDB 2003 A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9 300 306
16. CaiQMurakamiMSiHRobertsonES 2007 A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia. J Virol 81 10413 10423
17. BorahSVermaSCRobertsonES 2004 ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. J Virol 78 10336 10347
18. RadkovSAKellamPBoshoffC 2000 The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6 1121 1127
19. VermaSCBorahSRobertsonES 2004 Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol 78 10348 10359
20. YeFCZhouFCYooSMXieJPBrowningPJ 2004 Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J Virol 78 11121 11129
21. BarberaAJChodaparambilJVKelley-ClarkeBJoukovVWalterJC 2006 The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311 856 861
22. CotterMA2ndSubramanianCRobertsonES 2001 The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291 241 259
23. HuJGarberACRenneR 2002 The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76 11677 11687
24. HuJRenneR 2005 Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 79 2637 2642
25. LagunoffMGanemD 1997 The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236 147 154
26. VermaSCChoudhuriTRobertsonES 2007 The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner. J Virol 81 3402 3413
27. GarberACShuMAHuJRenneR 2001 DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75 7882 7892
28. BallestasMEKayeKM 2001 Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75 3250 3258
29. YatesJLCamioloSMBashawJM 2000 The minimal replicator of Epstein-Barr virus oriP. J Virol 74 4512 4522
30. DharSKYoshidaKMachidaYKhairaPChaudhuriB 2001 Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106 287 296
31. SchepersARitziMBoussetKKremmerEYatesJL 2001 Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J 20 4588 4602
32. ChaudhuriBXuHTodorovIDuttaAYatesJL 2001 Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc Natl Acad Sci U S A 98 10085 10089
33. VermaSCChoudhuriTKaulRRobertsonES 2006 Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol 80 2243 2256
34. StedmanWDengZLuFLiebermanPM 2004 ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 78 12566 12575
35. BlowJJHodgsonB 2002 Replication licensing—defining the proliferative state? Trends Cell Biol 12 72 78
36. VermaSCLanKChoudhuriTCotterMARobertsonES 2007 An autonomous replicating element within the KSHV genome. Cell Host Microbe 2 106 118
37. NorioPSchildkrautCL 2001 Visualization of DNA replication on individual Epstein-Barr virus episomes. Science 294 2361 2364
38. NorioPSchildkrautCL 2004 Plasticity of DNA replication initiation in Epstein-Barr virus episomes. PLoS Biol 2 e152
39. SfeirAKosiyatrakulSTHockemeyerDMacRaeSLKarlsederJ 2009 Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138 90 103
40. GuanZHughesCMKosiyatrakulSNorioPSenR 2009 Decreased replication origin activity in temporal transition regions. J Cell Biol 187 623 635
41. AladjemMI 2007 Replication in context: dynamic regulation of DNA replication patterns in metazoans. Nat Rev Genet 8 588 600
42. MachidaYJHamlinJLDuttaA 2005 Right place, right time, and only once: replication initiation in metazoans. Cell 123 13 24
43. TakedaDYShibataYParvinJDDuttaA 2005 Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells. Genes Dev 19 2827 2836
44. BlowJJDuttaA 2005 Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6 476 486
45. StillmanB 2005 Origin recognition and the chromosome cycle. FEBS Lett 579 877 884
46. BellSPDuttaA 2002 DNA replication in eukaryotic cells. Annu Rev Biochem 71 333 374
47. MizushimaTTakahashiNStillmanB 2000 Cdc6p modulates the structure and DNA binding activity of the origin recognition complex in vitro. Genes Dev 14 1631 1641
48. DePamphilisML 2005 Cell cycle dependent regulation of the origin recognition complex. Cell Cycle 4 70 79
49. DuttaABellSP 1997 Initiation of DNA replication in eukaryotic cells. Annu Rev Cell Dev Biol 13 293 332
50. CaiQVermaSCLuJRobertsonES 2010 Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 78 87 142
51. VermaSCLanKRobertsonE 2007 Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312 101 136
52. GodfreyAAndersonJPapanastasiouATakeuchiYBoshoffC 2005 Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105 2510 2518
53. KomatsuTBallestasMEBarberaAJKelley-ClarkeBKayeKM 2004 KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 319 225 236
54. BoehmerPELehmanIR 1997 Herpes simplex virus DNA replication. Annu Rev Biochem 66 347 384
55. VogelauerMRubbiLLucasIBrewerBJGrunsteinM 2002 Histone acetylation regulates the time of replication origin firing. Mol Cell 10 1223 1233
56. TothZMaglinteDTLeeSHLeeHRWongLY 2010 Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6 e1001013
57. WeiXSamarabanduJDevdharRSSiegelAJAcharyaR 1998 Segregation of transcription and replication sites into higher order domains. Science 281 1502 1506
58. PomerantzRTO'DonnellM 2008 The replisome uses mRNA as a primer after colliding with RNA polymerase. Nature 456 762 766
59. SchultzSSDesbordesSCDuZKosiyatrakulSLipchinaI 2010 Single-molecule analysis reveals changes in the DNA replication program for the POU5F1 locus upon human embryonic stem cell differentiation. Mol Cell Biol 30 4521 4534
60. RitziMTillackKGerhardtJOttEHummeS 2003 Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J Cell Sci 116 3971 3984
61. VermaSCLanKChoudhuriTRobertsonES 2006 Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. J Virol 80 3445 3458
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 11
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Multiple Candidate Effectors from the Oomycete Pathogen Suppress Host Plant Immunity
- The Splicing Factor Proline-Glutamine Rich (SFPQ/PSF) Is Involved in Influenza Virus Transcription
- A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis
- Simple Rapid Near-Patient Diagnostics for Tuberculosis Remain Elusive—Is a “Treat-to-Test” Strategy More Realistic?